Monday, December 16, 2024
HomeTagsInterim Data

Interim Data

BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability

BioVaxys Technology Corp. is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is...

Moleculin Announces Preliminary Third Cohort Interim Data in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary interim...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics